Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | APP | P05067 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30163514 | 0.92 | ALDH1A1 (0.60) | KDM4EALDH1A1SMN1; SMN2TDP1MAPT | |
| SCHEMBL30163547 | 0.87 | ALDH1A1 (0.53) | ALDH1A1SMN1; SMN2TDP1MAPTMAPK1 | |
| SCHEMBL30163485 | 0.86 | MAPT (0.53) | KDM4EALDH1A1SMN1; SMN2TDP1MAPT | |
| SCHEMBL30163501 | 0.83 | ALDH1A1 (0.58) | KDM4EALDH1A1SMN1; SMN2MAPTMAPK1 | |
| SCHEMBL31429081 | 0.83 | MAPT (0.53) | KDM4EALDH1A1SMN1; SMN2TDP1MAPT | |
| SCHEMBL31428961 | 0.83 | MAPT (0.51) | KDM4EALDH1A1SMN1; SMN2TDP1MAPT | |
| SCHEMBL31428724 | 0.82 | FKBP1A (0.53) | KDM4EALDH1A1SMN1; SMN2TDP1MAPT | |
| SCHEMBL31428963 | 0.82 | MAPT (0.53) | KDM4EALDH1A1SMN1; SMN2TDP1MAPT | |
| SCHEMBL31428792 | 0.82 | ALDH1A1 (0.53) | KDM4EALDH1A1SMN1; SMN2TDP1MAPT | |
| SCHEMBL31428936 | 0.82 | ALDH1A1 (0.59) | KDM4EALDH1A1SMN1; SMN2TDP1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250091994-A1 | RAS/RAF BINDING INHIBITOR COMPOUND | NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) | 2025-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250091994-A1 | RAS/RAF BINDING INHIBITOR COMPOUND | BRAF, RAF1, NRAS | KDM4E 2663/4885ALDH1A1 2352/4885SMN1; SMN2 4832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.